Patents by Inventor Yanrong Su

Yanrong Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment Of Females Having BRCA1/2 Mutations With Human Chorionic Gonadotropin To Reduce The Risk Of Developing Breast Cancer
    Publication number: 20240000895
    Abstract: Methods of treating nulligravid females having a high risk of developing breast cancer and without exposure to a contraceptive by administering human chorionic gonadotropin (hCG), methods of monitoring the treatment efficacy of a subject having breast cancer or having a high risk of developing breast cancer, and methods of determining whether a subject is at risk of developing breast cancer are provided herein.
    Type: Application
    Filed: December 6, 2021
    Publication date: January 4, 2024
    Inventors: Jose Russo, Herman Depypere, Yanrong Su, Nhi Dang, Jaak Janssens
  • Human chorionic gonadotropin variant peptides and treatment of breast cancer
    Patent number: 11697674
    Abstract: The present disclosure provides hCG variant proteins, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of treating cancer.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: July 11, 2023
    Assignee: Institute For Cancer Research
    Inventors: Jose Russo, Yanrong Su, Julia Santucci Pereira Del Buono, Mark Andrake
  • HUMAN CHORIONIC GONADOTROPIN VARIANT PEPTIDES AND TREATMENT OF BREAST CANCER
    Publication number: 20220041679
    Abstract: The present disclosure provides hCG variant proteins, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of treating cancer.
    Type: Application
    Filed: October 15, 2018
    Publication date: February 10, 2022
    Applicant: Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center
    Inventors: Jose Russo, Yanrong Su, Julia Santucci Pereira Del Buono, Mark Andrake
  • HUMAN CHORIONIC GONADOTROPIN VARIANT PEPTIDES AND TREATMENT OF BREAST CANCER
    Publication number: 20210188935
    Abstract: The present disclosure provides hCG variant proteins, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of treating cancer.
    Type: Application
    Filed: October 15, 2018
    Publication date: June 24, 2021
    Applicant: Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center
    Inventors: Jose Russo, Yanrong Su, Julia Santucci Pereira Del Buono, Mark Andrake